Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes

This publication has 18 references indexed in Scilit:

• Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease
  Circulation, 2001
• Importance of Early Insulin Secretion
  Diabetes Care, 2001
• Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in Type 2 diabetes mellitus
  Diabetic Medicine, 2000
• Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease
  Circulation, 1999
• Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study
  Diabetes Care, 1998
• Postprandial Elevation of ApoB-48-Containing Triglyceride-Rich Particles and Retinyl Esters in Normolipemic Males Who Smoke
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM
  Diabetologia, 1997
• Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (−)‐N‐(trans‐4‐isopropylcyclohexane‐carbonyl)‐d‐phenylalanine (A‐4166)
  British Journal of Pharmacology, 1997
• Diabetic Dyslipidemia: Basic Mechanisms Underlying the Common Hypertriglyceridemia and Low HDL Cholesterol Levels
  Diabetes, 1996
• Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
  Circulation, 1990